🎉 M&A multiples are live!
Check it out!

Valbiotis Valuation Multiples

Discover revenue and EBITDA valuation multiples for Valbiotis and similar public comparables like Sanofi India, Procter & Gamble Health, and Mega Lifesciences.

Valbiotis Overview

About Valbiotis

Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.


Founded

2014

HQ

France
Employees

38

Website

valbiotis.com

Financials

LTM Revenue $2.1M

LTM EBITDA -$10.5M

EV

$11.0M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Valbiotis Financials

Valbiotis has a last 12-month revenue of $2.1M and a last 12-month EBITDA of -$10.5M.

In the most recent fiscal year, Valbiotis achieved revenue of $0.2M and an EBITDA of -$9.9M.

Valbiotis expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Valbiotis valuation multiples based on analyst estimates

Valbiotis P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $5.1M $0.2M XXX XXX XXX
Gross Profit $0.8M $2.9M XXX XXX XXX
Gross Margin 16% 1525% XXX XXX XXX
EBITDA -$6.9M -$9.9M XXX XXX XXX
EBITDA Margin -135% -5241% XXX XXX XXX
Net Profit -$13.2M -$7.9M XXX XXX XXX
Net Margin -260% -4210% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Valbiotis Stock Performance

As of April 15, 2025, Valbiotis's stock price is EUR 1 (or $1).

Valbiotis has current market cap of EUR 16.1M (or $17.3M), and EV of EUR 10.2M (or $11.0M).

See Valbiotis trading valuation data

Valbiotis Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$11.0M $17.3M XXX XXX XXX XXX $-0.69

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Valbiotis Valuation Multiples

As of April 15, 2025, Valbiotis has market cap of $17.3M and EV of $11.0M.

Valbiotis's trades at 5.3x LTM EV/Revenue multiple, and -1.0x LTM EBITDA.

Analysts estimate Valbiotis's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Valbiotis and 10K+ public comps

Valbiotis Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $11.0M XXX XXX XXX
EV/Revenue 58.4x XXX XXX XXX
EV/EBITDA -1.1x XXX XXX XXX
P/E -1.6x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -0.9x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Valbiotis Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Valbiotis Valuation Multiples

Valbiotis's NTM/LTM revenue growth is 140%

Valbiotis's revenue per employee for the last fiscal year averaged $5K, while opex per employee averaged $0.2M for the same period.

Over next 12 months, Valbiotis's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Valbiotis's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Valbiotis and other 10K+ public comps

Valbiotis Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -96% XXX XXX XXX XXX
EBITDA Margin -5241% XXX XXX XXX XXX
EBITDA Growth 43% XXX XXX XXX XXX
Rule of 40 (SaaS-only) -5101% XXX XXX XXX XXX
Revenue per Employee $5K XXX XXX XXX XXX
Opex per Employee $0.2M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 2650% XXX XXX XXX XXX
Opex to Revenue 4561% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Valbiotis Public Comps

See public comps and valuation multiples for Nutraceuticals & Cosmeceuticals comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
SynBiotic XXX XXX XXX XXX XXX XXX
Mega Lifesciences XXX XXX XXX XXX XXX XXX
Procter & Gamble Health XXX XXX XXX XXX XXX XXX
Abbott India XXX XXX XXX XXX XXX XXX
Sanofi India XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Valbiotis M&A and Investment Activity

Valbiotis acquired  XXX companies to date.

Last acquisition by Valbiotis was  XXXXXXXX, XXXXX XXXXX XXXXXX . Valbiotis acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Valbiotis

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Valbiotis

When was Valbiotis founded? Valbiotis was founded in 2014.
Where is Valbiotis headquartered? Valbiotis is headquartered in France.
How many employees does Valbiotis have? As of today, Valbiotis has 38 employees.
Is Valbiotis publicy listed? Yes, Valbiotis is a public company listed on PAR.
What is the stock symbol of Valbiotis? Valbiotis trades under ALVAL ticker.
When did Valbiotis go public? Valbiotis went public in 2017.
Who are competitors of Valbiotis? Similar companies to Valbiotis include e.g. SynBiotic, Mega Lifesciences, Procter & Gamble Health, Abbott India.
What is the current market cap of Valbiotis? Valbiotis's current market cap is $17.3M
What is the current revenue of Valbiotis? Valbiotis's last 12-month revenue is $2.1M.
What is the current EBITDA of Valbiotis? Valbiotis's last 12-month EBITDA is -$10.5M.
What is the current EV/Revenue multiple of Valbiotis? Current revenue multiple of Valbiotis is 5.3x.
What is the current EV/EBITDA multiple of Valbiotis? Current EBITDA multiple of Valbiotis is -1.0x.
What is the current revenue growth of Valbiotis? Valbiotis revenue growth between 2023 and 2024 was -96%.
Is Valbiotis profitable? Yes, Valbiotis is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.